is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus that causes coronavirus disease 2019 (COVID‑19).
Rostec and the Perm Krai signed a memorandum on co-operation in implementation of two large investment projects. Within the partnership, a new vaccine production...
NPO Microgen (managed by Nacimbio of Rostec State Corporation) announced the registration of bivalent polysaccharide vaccine for the prevention of meningococcal infection by the...